3 Fabulous Dividend Stocks to Buy in February
Any time is a good time to buy solid dividend stocks. But this month is a special time to do so for one simple reason: There's an extra day for investors to buy stocks because it's a leap year.
Three Motley Fool contributors have picked what they believe are fabulous dividend stocks to buy in February. Here's why they chose (NYSE: ABBV), Novartis (NYSE: NVS), and Pfizer (NYSE: PFE).
Prosper Junior Bakiny (AbbVie): Drugmaker AbbVie was hardly a hot commodity last year. The company lost patent exclusivity in the U.S. for the most important growth driver in its arsenal in the past decade: immunology medicine Humira. AbbVie's revenue dropped as a result.
Source Fool.com
AbbVie Inc. Stock
€170.56
1.510%
With 32 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 176 € there is a slightly positive potential of 3.19% for AbbVie Inc. compared to the current price of 170.56 €.
